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Abstract
Background: During acute coronary syndromes patients perceive intense distress. We hypothesized that
retrospective ratings of patients’ MI-related fear of dying, helplessness, or pain, all assessed within the first year
post-MI, are associated with poor cardiovascular outcome.
Methods: We studied 304 patients (61 ± 11 years, 85% men) who after a median of 52 days (range 12-365 days)
after index MI retrospectively rated the level of distress in the form of fear of dying, helplessness, or pain they had
perceived at the time of MI on a numeric scale ranging from 0 ("no distress”) to 10 ("extreme distress”). Non-fatal
hospital readmissions due to cardiovascular disease (CVD) related events (i.e., recurrent MI, elective and non-elective
stent implantation, bypass surgery, pacemaker implantation, cerebrovascular incidents) were assessed at follow-up.
The relative CVD event risk was computed for a (clinically meaningful) 2-point increase of distress using Cox
proportional hazard models.
Results: During a median follow-up of 32 months (range 16-45), 45 patients (14.8%) experienced a CVD-related
event requiring hospital readmission. Greater fear of dying (HR 1.21, 95% CI 1.03-1.43), helplessness (HR 1.22, 95% CI
1.04-1.44), or pain (HR 1.27, 95% CI 1.02-1.58) were significantly associated with an increased CVD risk without
adjustment for covariates. A similarly increased relative risk emerged in patients with an unscheduled CVD-related
hospital readmission, i.e., when excluding patients with elective stenting (fear of dying: HR 1.26, 95% CI 1.05-1.51;
helplessness: 1.26, 95% CI 1.05-1.52; pain: HR 1.30, 95% CI 1.01-1.66). In the fully-adjusted models controlling for
age, the number of diseased coronary vessels, hypertension, and smoking, HRs were 1.24 (95% CI 1.04-1.46) for fear
of dying, 1.26 (95% CI 1.06-1.50) for helplessness, and 1.26 (95% CI 1.01-1.57) for pain.
Conclusions: Retrospectively perceived MI-related distress in the form of fear of dying, helplessness, or pain was
associated with non-fatal cardiovascular outcome independent of other important prognostic factors.
Keywords: Myocardial infarction, pain, retrospective study, psychological stress, risk factor
Background
Myocardial infarction (MI) is an unexpected life-threaten-
ing event which is perceived as stressful by many patients
who may expect death or serious disability [1,2]. For
instance, after symptom onset three out of four patients
with an acute coronary syndrome (ACS) indicated to have
experienced moderate or high levels of MI-related distress,
including being frightened and thinking they might be
dying when symptoms came on [3]. In another study, fear
of dying and perceived severity of MI (e.g. fright of recur-
rent chest pain) together accounted for more than half of
the variance in distress perceived during MI [4]. Fear of
dying and distress were also highly associated with inten-
sity of chest pain at the time of MI [3]. Given that chest
pain experience is greatly modulated by affective states [5],
chest pain intensity was discussed as an equivalent of emo-
tional distress perceived at the time of MI [3].
Distress during ACS profoundly impacts psychological
adjustment in the wake of the cardiac event, particularly
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bringing on symptoms of anxiety, depression, and post-
traumatic stress disorder. For instance, patients who
were more distressed and frightened during ACS
showed higher levels of anxiety and depressive symp-
toms, one week and three months, respectively, after the
cardiac event [3]. Fright and the intensity of acute pain
during ACS were both associated with posttraumatic
stress symptoms three months later [6,7]. We found
that retrospectively assessed levels of MI-related fear of
dying, helplessness, or pain were associated with post-
traumatic stress symptoms after a median of 40 days fol-
lowing MI [8].
The aforementioned studies suggest that distress con-
ceptualized as MI-related fear of dying, helplessness or
pain might be an important clinical entity, since it is
associated with negative affective risk factors for cardio-
vascular morbidity and mortality, including depression,
anxiety, and posttraumatic stress disorder [9-11]. Vir-
tually all descriptions of negative affect distinguish
among anxiety and related constructs (e.g. fear) and
depression and related constructs (e.g. helplessness)
[12]. Therefore, MI-related fear of dying and helpless-
ness could be understood as part of the negative affec-
tive spectrum being associated with poor cardiovascular
prognosis in the aftermath of MI. Moreover, increasing
attempts have been made to dismantle negative affective
constructs in order to identify for instance the “cardio-
toxic” components of depression in patients with coron-
ary heart disease [13]. In other words, MI-related fear of
dying and helplessness may seem to tap into specific
qualities of negative affect, thereby having the potential
to emerge as risk factors of poor cardiovascular prog-
nosis and as specific targets for behavioral interventions
in their own right. Several processes might help to
explain the putative relation between MI-related distress
and subsequent CVD-related events. As has been shown
for other types of negative affect, these might relate to
poor life style choices, low adherence with cardiac ther-
apy, and distinct pathophysiologic processes directly
harming the cardiovascular system [14].
As a first step of testing the value of MI-related distress
for post-MI prognosis, we investigated the hypothesis that
greater fear of dying, helplessness, or pain intensity (i.e.,
perceived distress during acute MI) would be associated
with increased risk of future hospital readmissions due to
non-fatal cardiovascular events and related interventions.
We further hypothesized that MI-related distress would be
associated with poor cardiovascular outcome independent
of other important prognostic factors.
Methods
Study participants
All participants provided written informed consent to
the study protocol that was approved by the ethics
committee of the Canton of Bern, Switzerland, as part
of the ongoing longitudinal Swiss Heart and Mind
Study. The flowchart shows the recruitment of the 304
patients available for the present investigation. As pre-
viously detailed [15], between 01/2005 and 04/2007, we
approached 951 consecutive patients referred to the
Department of Cardiology, Inselspital, Bern University
Hospital, Switzerland. Inclusion criteria were a verified
acute ST-elevation or non-ST-elevation MI, living within
a 90-min drive from the University Hospital, and suffi-
cient knowledge of German. Response rate was 44.8%
(426/951). Within a median of 52 days (range 12-365),
participants in the present study were sent home rating
scales to assess distress perceived during MI. For the
follow-up investigation, patients were contacted again by
mail and asked for their consent to participate in assess-
ment of cardiovascular outcome since assessment of
MI-related distress.
Assessment of patient characteristics
Patient characteristics including sex, age, type of index
MI (first-time vs. recurrent MI), left ventricular ejection
fraction (LVEF) measured by ventriculography during
coronary angiography, and the number of diseased cor-
onary vessels, were abstracted from hospital charts
recorded at the time of the index MI. Hypertension
(yes/no) was defined by either a positive history for
treatment or systolic and/or diastolic blood pressure
≥140/90 mmHg at rest. Diabetes (yes/no) was defined
by a positive history that, if unclear, was verified by one-
time glucose level >200 mg/dl. The status of current
smoking (yes/no) was also obtained from the charts.
Data on LVEF, hypertension, diabetes, and smoking sta-
tus were missing in 9 (3.0%), 6 (2.0%), 14 (4.6%), and 15
(4.9%) patients, respectively. The use (yes/no) of aspirin,
statins, beta blockers, and angiotensin-converting
enzyme (ACE) inhibitors was noted with respective data
missing in 4 (1.3%), 5 (1.6%), 9 (3.0%), and 4 (1.3%)
patients, respectively.
Assessment of distress perceived during myocardial
infarction
The patients retrospectively rated three aspects of sub-
jective perception of distress related to MI on a numeric
rating ranging from 0 to 10 points [8]: a) fear of dying:
“During my referral to the hospital, the emergency unit,
or the intensive care unit, I was afraid I was dying.” (0 =
absolutely not true, 10 = absolutely true); b) helplessness:
“When the doctor told me I had a heart attack, I was
frightened, felt helpless, and was afraid of losing control
of the situation.” (0 = absolutely not true, 10 = abso-
lutely true); c) pain intensity: “Please indicate how
strong your pain was during the heart attack.” (0 = no
pain at all, 10 = intolerable pain). Cronbach’s alpha for
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the three scales was 0.76 suggesting acceptable reliability
for the measured construct of “MI-related distress”.
Assessment at follow-up
The follow-up period referred to the time interval
between assessment of distress and a semi-structured tel-
ephone interview during which patients were asked
whether they had been hospitalized because of a new car-
diovascular event or related intervention specified as fol-
lows a priori: recurrent MI, elective and non-elective
percutaneous coronary intervention with stent implanta-
tion, coronary artery bypass grafting, pacemaker implan-
tation, cardiac arrhythmia, cardiac arrest, cerebrovascular
insult, transient ischemic attack, hypertensive crisis, heart
failure. A positive answer was verified by contacting the
treating physician by phone. We also asked whether the
patient had received mental health treatment (i.e. antide-
pressants, psychotherapy) and whether he or she had had
non-specific chest pain after the index MI. Eleven
patients confirmed the latter and were excluded from the
analysis because thoracic pain might potentially affect
retrospective ratings of distress.
Statistical analysis
Data were analyzed using SPSS 15.0 statistical software
package (SPSS Inc. Chicago, IL). Two-tailed level of sig-
nificance was set at p < 0.05. Differences between
groups were calculated using Student’s t test, Pearson
chi-square test, and Fisher’s exact test where appropri-
ate. Pearson correlation coefficients were computed to
estimate the correlation between two variables. We ran
three separate Cox proportional hazard models to esti-
mate the relative risk (hazard ratio with 95% confidence
interval) of a hospital readmission during follow-up
because of a CVD event or CVD-related intervention
(combined endpoint) as the outcome in relation to a
2-point increase of MI-related distress ratings. That is,
we first assessed distress measures with the 10-point
scale, then divided the score by two, and used the
obtained value in analysis. Using a 0 to 10 numeric rat-
ing scale, changes of approximately 2 points or 30% to
36% represent clinically meaningful changes in pain
severity [16]. For the sake of consistency, we similarly
judged a change of 2 points on the 0 to 10 numeric rat-
ing scales for fear of dying and helplessness to be clini-
cally meaningful.
To avoid overfitted and thus unstable models, the 45
outcome events (Figure 1) allowed us to force a maxi-
mum of four potentially confounding variables in addi-
tion to the respective distress measure (i.e., a maximum
of five independent variables) all in one block into the
equation [17]. Confounders of recurrent cardiac events
in post-MI patients were defined a priori, being age [18]
severity of CHD, as indexed by the number of diseased
coronary vessels [19], and the major CVD risk factors
hypertension [20] and smoking [21].
Results
Patient characteristics and cardiovascular readmissions
The median duration of follow-up after assessment of
MI-related distress measures was 32 months (range 16-
45) during which a CVD-related hospital readmission
occurred in 45 patients (14.8%). The type of CVD events
and interventions is shown in Figure 1. The characteris-
tics of the entire sample as well as stratified by CVD-
related readmission are given in Table 1. Compared to
patients with no CVD-related readmission, those who
experienced a cardiovascular event or related interven-
tion were more frequently hypertensive and scored
higher on all distress ratings. No group difference was
seen in terms of demographic characteristics, severity of
CHD, cardiac medication, and mental health treatment.
Bivariate correlations with distress measures related to
myocardial infarction
There were positive associations among all distress mea-
sures; i.e., between fear of dying and helplessness (r =
0.79, p < 0.001), fear of dying and pain (r = 0.40, p <
0.001), and helplessness and pain (r = 0.33, p < 0.001).
More time elapsed since the MI correlated with greater
fear of dying (r = 0.12, p = 0.032) but not significantly
so with helplessness or pain. Younger age was associated
with higher scores of fear of dying (r = -0.24, p < 0.001),
helplessness (r = -0.23, p < 0.001), and pain (r = -0.16, p
= 0.006). Smokers showed greater helplessness than non-
smokers (3.35 ± 3.57 vs. 2.44 ± 2.71, p = 0.020). Patients
who had received antidepressant medication indicated
greater fear of dying (3.94 ± 3.63 vs. 2.56 ± 3.10, p =
0.040), greater helplessness (3.88 ± 3.42 vs. 2.62 ± 3.04,
p = 0.025), and more intense pain (6.94 ± 3.11 vs. 5.90 ±
2.88, p < 0.049) during MI than those who were not pre-
scribed antidepressants. There were no significant corre-
lations between any distress measure and gender,
hypertension, diabetes, measures of CHD severity, car-
diac medications, and psychotherapy since index MI.
MI-related distress and CVD-related hospital readmissions
As shown in Table 2, for a 2-point increase in fear of
dying, helplessness, or pain, there was a respective
increase of 21%, 22%, and 27% in the relative risk of a
CVD-related hospital readmission without adjustment
for covariates. No one distress measure turned out to be
significant if entered together in one block into the
equation (fear of dying: HR 1.05, 95% CI 0.79-1.39, p =
0.74; helplessness: 1.12, 95% CI 0.85-1.49, p = 0.41; pain:
HR 1.18, 95% CI 0.94-1.50, p = 0.16).
It is possible that at the time of distress assessment,
the 10 patients who underwent elective stenting during
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follow-up already knew about a planned readmission
such that they might differ in their distress ratings from
the 35 patients who experienced an unscheduled CVD-
related event. Therefore, we conducted a sensitivity ana-
lysis excluding patients having undergone elective stent
implantation; this analysis showed an increase in the
relative risk for an unscheduled CVD-related hospital
readmission of 26%, 26%, and 30%, respectively, for a 2-
point increase in fear of dying, helplessness, or pain
(Table 2).
Table 3 shows the multivariate-adjusted hazard mod-
els that included 286 patients of whom 43 experienced a
CVD-related hospital readmission during follow-up.
Compared to the results from the unadjusted analysis
(Table 2), the effect size of the relationship between a 2-
point increase in any distress measure and the relative
Figure 1. Flowchart: recruitment of 304 eligible patients with myocardial infarction  
n=951 patients with index MI and meeting inclusion criteria approached 
525: did not respond to survey
n=426 returned NRS asking for fear of dying, helplessness, and pain perceived during MI 
    16: had died 
    16: declined to participate 
n=394 consented to participate in the follow-up investigation 
    11: index MI >1 year ago 
    9: missing items on NRS 
    44: no outcome data (e.g., not responding, no interest) 
    6: died during follow-up 
    9: CVD-related readmissions before completing NRS 
    11: unexplained chest pain since index MI 
n=304 available for follow-up investigation  
   n=259: no CVD-related hospital readmission during follow-up 
n=45 hospital readmissions because of CVD-related events 
12 recurrent MI 
12 non-elective PCI with stent implantation 
10 elective PCI with stent implantation 
4 coronary artery bypass graft 
2 pace-maker implantation 
5 cerebrovascular events 
Figure 1 CVD, cardiovascular disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; NRS, numeric rating scale.
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risk of a CVD-related event was maintained or increased
even slightly when taking into account age, the number
of diseased coronary vessels, hypertension, and smoking.
Hypertension, but not age, the number of diseased cor-
onary vessels, and smoking emerged as a significant pre-
dictor of outcome in all of the three multivariate
models.
Discussion
We investigated the association between retrospectively
rated MI-related fear of dying, helplessness, or pain
intensity and non-fatal CVD outcome. These measures
showed acceptable reliability for a construct of “MI-
related distress” and they are also shown to be clinically
important because of their predictive value for poor
psychological adjustment during recovery from MI
[3,6-8]. We found that MI-related distress was asso-
ciated with an increased risk of hospital readmissions
due to cardiovascular events and related interventions
during a mean follow-up of almost three years. This
association was independent of potentially important
prognostic factors, namely age, coronary heart disease
severity, hypertension and smoking: of these, hyperten-
sion alone emerged as a significant predictor of event
risk. The relations between MI-related distress measures
and CVD event risk seems relevant, as a change of 2
points (or between 30% and 36%) in pain intensity on
numeric rating scales ranging from 0 to 10 is considered
to be clinically meaningful [16]. In our patients a 33%
increase in distress severity would mean an increase in
distress scores from 6 to 8 corresponding to a 1.2- to
1.4-fold increased risk of CVD-related hospital
readmissions.
Our study is on the one hand to be understood as a
first attempt of tracking down the prognosis of post-MI
patients who perceive their MI as stressful. On the
other, it suggests that MI-related distress does not only
predict psychological adjustment post-MI, as was pre-
viously shown [3,6-8], but also CVD outcome. In other
words, the focus of our study was to investigate the pos-
sibly direct association between distress and poor CVD
outcome in post-MI patients by taking demographic fac-
tors, CHD severity, and major CVD risk factors into
account. However, because psychological adjustment
post-MI was variously predicted by distress measures,
Table 1 Characteristics of 304 patients per cardiovascular disease readmissions
All (n = 304) Readmission (n = 45) No readmission (n = 259) p-value
Women (%) 15.5 6.7 17.0 0.115
Age (years) 60.9 ± 10.6 59.9 ± 11.1 61.0 ± 10.5 0.512
Time between MI and distress assessment (days) 74.7 ± 57.8 71.2 ± 54.5 75.3 ± 58.4 0.669
Recurrent MI (%) 9.5 11.1 9.3 0.782
1-, 2-, 3-vessel disease (%) 43.4, 32.6, 24.0 28.9, 42.2, 28.9 45.9, 30.9, 23.2 0.100
Left ventricular ejection fraction (%) 50.1 ± 10.6 50.5 ± 9.2 50.0 ± 10.9 0.794
Hypertension (%) 60.4 75.0 57.9 0.032
Diabetes (%) 11.7 9.3 12.1 0.798
Current smoker (%) 40.8 45.5 40.0 0.509
Aspirin (%) 98.3 100 98.1 1.000
Statin (%) 96.7 100 96.1 0.367
Beta blocker (%) 89.5 92.7 92.1 1.000
ACE inhibitor (%) 68.9 69.8 68.8 0.894
Antidepressants (%) 11.2 13.3 10.8 0.610
Psychotherapy (%) 7.9 4.4 8.5 0.550
Fear of dying (score) 2.71 ± 3.18 3.78 ± 3.57 2.53 ± 3.08 0.015
Helplessness (score) 2.76 ± 3.10 3.82 ± 3.54 2.58 ± 2.99 0.030
Pain (score) 6.01 ± 2.92 6.87 ± 2.91 5.86 ± 2.90 0.033
ACE, angiotensin-converting enzyme; MI, myocardial infarction.
Table 2 Unadjusted relative risk (95% CI) of distress
measures for cardiovascular disease-related hospital
readmissions
Distress Measure All events
(n = 304, 45 events)
Unscheduled events
(n = 294, 35 events)
Fear of dying 1.21 (1.03-1.43) 1.26 (1.05-1.51)
p = 0.020 p = 0.012
Helplessness 1.22 (1.04-1.44) 1.26 (1.05-1.52)
p = 0.017 p = 0.013
Pain 1.27 (1.02-1.58) 1.30 (1.01-1.66)
p = 0.033 p = 0.042
Relative risks are expressed for a 2-point increase on numeric rating scales for
distress measures. Unscheduled events do not include elective stent
implantation that occurred during follow-up.
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including fear of dying, helplessness, or pain intensity
[6-9], the extent to which distress is associated with
poor CVD prognosis independent from its psychological
sequel remains unresolved.
Patients reporting greater levels of all distress mea-
sures received more frequently antidepressant medica-
tion during follow-up. However, we do not know the
type of antidepressants our patients received. For
instance, particularly selective serotonin reuptake inhibi-
tors seem to improve CVD outcome [22]. Further eluci-
dation of the likely complex psychological pathways
leading from MI-related distress to poor CVD prognosis
is warranted, because these might provide cues for tai-
lored behavioral interventions. For instance, patients
might profit from reassurance and provided safety dur-
ing MI [3] and later on from more trauma-focused cog-
nitive behavioral therapy [23]. Our observation that
distress measures correlated inversely with age might
indicate that younger patients are in particular need of
psychological support during MI.
In addition to psychological maladjustment, other
explanations for the association between greater MI-
related distress and an increased future risk of CVD
events might relate to an unhealthy life style, poor com-
pliance with cardiac therapy, and psychophysiologic
alterations [14]. In our study, smokers showed greater
helplessness than non-smokers. In another study, good
medical recovery from MI was associated with positive
life orientation, which in turn correlated inversely with
helplessness [24]. Psychological stress is also associated
with an unhealthy diet, physical inactivity, and sleep dis-
turbances, all of which may impact cardiovascular health
[14], but were not available in our study. Particularly
distress and fear during ACS were shown to be lower in
regular exercisers than in patients who exercised less
frequently [3]. Depression and PTSD compromise pre-
scribed intake of cardiac medication [25,26], thereby
suggesting another pathway leading from distress via
psychological maladjustment and poor adherence to
increased CVD risk. Future studies may also want to
investigate the physiologic correlates of distress during
MI to investigate their trajectories and predictive value
for CVD-related events. For instance, there is some evi-
dence that elevated heart rate and lowered cortisol in
the immediate aftermath of a psychological trauma pre-
dict the development of posttraumatic stress symptoms
[27,28]. However, it is unknown how this might affect
cardiovascular biology in the longer run.
We observed different results when entering all dis-
tress measures simultaneously into the survival analysis,
namely that distress was no longer associated with out-
comes. Because the inter-correlation among the three
distress measures was substantial, one statistical expla-
nation could be that their separate effects partialled out
each other. Another explanation could be that none of
the distress measure components was associated with
outcomes above and beyond one another suggesting
that they might be equally important in predicting car-
diac outcome individually. In other words, as the three
distress measures might substitute for each other, it
might seem unnecessary to measure all of them in soli-
tude. However, future studies may want to test how dis-
tress measures as proposed here and possibly others
might best be integrated into a unifying measure of dis-
tress to reliably predict cardiac prognosis after MI.
We mention several limitations of our study. Although
comparable with our studies in this field, the response
rate of 44.8% of the originally approached 951 patients
was rather low, and, as previously reported, women
responded less than men [9]. This might limit the gen-
eralizibility of our results to the general post-MI popula-
tion and particularly women patients. We assessed MI-
related distress retrospectively bearing the risk of biased
reporting because of concomitant negative affect. We
did not assess negative affect like depression and anxiety
to control our results for this possibility. However,
another study found only borderline significance
between a negative affect scale and distress (including
fear of dying) during ACS [3]. Patients varied consider-
ably in time since index MI which might have variably
Table 3 Multivariate-adjusted relative risk (95% CI) of
distress measures for cardiovascular disease-related
hospital readmissions
Entered variables Fear of dying Helplessness Pain
Fear of dying 1.24 (1.04-1.46) – –
p = 0.015
Helplessness – 1.26 (1.06-1.50) –
p = 0.010
Pain – – 1.26 (1.01-1.57)
p = 0.042
Age 1.01 (0.87-1.19) 1.01 (0.87-1.18) 0.99 (0.85-1.15)
p = 0.86 p = 0.87 p = 0.92
1-, 2-, 3-vessel
disease
1.27 (0.88-1.84) 1.27 (0.88-1.83) 1.26 (0.87-1.83)
p = 0.20 p = 0.21 p = 0.22
Hypertension 2.10 (1.02-4.36) 2.22 (1.07-4.60) 2.13 (1.03-4.39)
p = 0.046 p = 0.033 p = 0.040
Smoking 1.24 (0.66-2.36) 1.22 (0.64-2.32) 1.20 (0.63-2.30)
p = 0.50 p = 0.56 p = 0.58
Model statistics c2 = 14.01,
df = 5,
c2 = 14.64,
df = 5,
c2 = 12.03,
df = 5,
p = 0.016 p = 0.012 p = 0.034
All covariates were entered in one block together with the respective distress
measure. Relative risks are expressed for a 2-point increase on numeric rating
scales for distress measures and for a 5-year increase for age (i.e., age values
were divided by 5 before entering the equation). Because of missing data for
hypertension and smoking status, all models included 286 patients and 43
cardiovascular disease-related events.
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affected distress measurements; for instance, fear of
dying seemed to be greater with more time elapsed
since the index MI. We excluded patients who had
reported unexplained chest pain since index MI but we
did not have data available on symptoms such as thor-
acic pain the patients and their physicians might have
attributed to the heart. Such symptom attributions
might potentially affect retrospective reports of MI-
related distress. There might be events, which have hap-
pened during the time since index MI which may con-
tribute to the retrospective evaluation of distress (e.g.,
familial difficulties, death or other illnesses in the family,
economical problems) for which we could not control
our analysis. The number of outcome events limited the
adjustment of hazard models for additional potentially
important confounding variables like sex and diabetes.
Conclusions
The findings from this study suggest that retrospectively
assessed MI-related distress in the form of fear of dying,
helplessness, or pain intensity is associated with an
increased risk of future non-fatal cardiovascular events
and related interventions. Numeric rating scales to
assess symptom severity (incl. pain) are widely used in
clinical settings. Particularly, the numeric rating scales
applied in this study to measure distress are easy admin-
istrable even in a busy clinical setting and thus of poten-
tial clinical applicability in screening post-MI patients at
risk of poor cardiovascular outcome. The association
between MI-related distress and poor cardiac outcome
was independent of other important prognostic factors.
The downstream psychopathology and behavior as well
as the underlying physiology of this association remain
to be elucidated.
Acknowledgements
The authors wish to thank Annette Kocher for editorial support.
Author details
1Department of General Internal Medicine, Division of Psychosomatic
Medicine, Inselspital, Bern University Hospital, and University of Bern,
Switzerland. 2Swiss Cardiovascular Center, Cardiovascular Prevention and
Rehabilitation, Inselspital, Bern University Hospital, and University of Bern,
Switzerland.
Authors’ contributions
All authors participated in the design of the study, helped to draft the
manuscript and read and approved the final manuscript. RvK performed
statistical analysis and wrote the first draft of the manuscript. RH performed
all the telephone interviews. RH and JPS collected all the additional data
reported in this manuscript. RvK, SB and HS critically supervised data
acquirement and made important intellectual contribution to the
interpretation of the data.
Competing interests
The authors declare that they have no competing interests.
Received: 12 October 2010 Accepted: 10 June 2011
Published: 10 June 2011
References
1. Burnett RE, Blumenthal JA, Mark DB, Leimberger JD, Califf RM:
Distinguishing between early and late responders to symptoms of acute
myocardial infarction. Am J Cardiol 1995, 75:1019-1022.
2. Wikman A, Bhattacharyya M, Perkins-Porras L, Steptoe A: Persistence of
posttraumatic stress symptoms 12 and 36 months after acute coronary
syndrome. Psychosom Med 2008, 70:764-772.
3. Whitehead DL, Strike P, Perkins-Porras L, Steptoe A: Frequency of distress
and fear of dying during acute coronary syndromes and consequences
for adaptation. Am J Cardiol 2005, 96:1512-1516.
4. Ginzburg K, Solomon Z, Koifman B, Keren G, Roth A, Kriwisky M, Kutz I,
David D, Bleich A: Trajectories of posttraumatic stress disorder following
myocardial infarction: a prospective study. J Clin Psychiatry 2003,
64:1217-1223.
5. Sheps DS, Creed F, Clouse RE: Chest pain in patients with cardiac and
noncardiac disease. Psychosom Med 2004, 66:861-867.
6. Whitehead DL, Perkins-Porras L, Strike PC, Steptoe A: Post-traumatic stress
disorder in patients with cardiac disease: predicting vulnerability from
emotional responses during admission for acute coronary syndromes.
Heart 2006, 92:1225-1229.
7. Bennett P, Conway M, Clatworthy J, Brooke S, Owen R: Predicting
post-traumatic symptoms in cardiac patients. Heart Lung 2001,
30:458-465.
8. Wiedemar L, Schmid JP, Müller J, Wittmann L, Schnyder U, Saner H, von
Känel R: Prevalence and predictors of posttraumatic stress disorder in
patients with acute myocardial infarction. Heart Lung 2008, 37:113-121.
9. Frasure-Smith N, Lespérance F, Talajic M: Depression and 18-month
prognosis after myocardial infarction. Circulation 1995, 91:999-1005.
10. Huffman JC, Smith FA, Blais MA, Januzzi JL, Fricchione GL: Anxiety,
independent of depressive symptoms, is associated with in-hospital
cardiac complications after acute myocardial infarction. J Psychosom Res
2008, 65:557-563.
11. Shemesh E, Yehuda R, Milo O, Dinur I, Rudnick A, Vered Z, Cotter G:
Posttraumatic stress, nonadherence, and adverse outcome in survivors
of a myocardial infarction. Psychosom Med 2004, 66:521-526.
12. Smith TW: Conceptualization, measurement, and analysis of negative
affective risk factors. In Handbook of Behavioral Medicine. Edited by:
Steptoe A. New York: Springer; 2010:155-168.
13. Frasure-Smith N, Lespérance F: Depression and cardiac risk: present status
and future directions. Heart 2010, 96:173-176.
14. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L: The
epidemiology, pathophysiology, and management of psychosocial risk
factors in cardiac practice: the emerging field of behavioral cardiology. J
Am Coll Cardiol 2005, 45:637-651.
15. Guler E, Schmid JP, Wiedemar L, Saner H, Schnyder U, von Känel R: Clinical
diagnosis of posttraumatic stress disorder after myocardial infarction.
Clin Cardiol 2009, 32:125-129.
16. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT,
Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N,
Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S,
Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C,
McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA,
Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW,
von Stein T, White RE, Witter J, Zavisic S: Interpreting the clinical
importance of treatment outcomes in chronic pain clinical trials:
IMMPACT recommendations. J Pain 2008, 9:105-121.
17. Babyak MA: What you see may not be what you get: a brief,
nontechnical introduction to overfitting in regression-type models.
Psychosom Med 2004, 66:411-421.
18. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F,
Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB:
Prediction of risk of death and myocardial infarction in the six months
after presentation with acute coronary syndrome: prospective
multinational observational study (GRACE). BMJ 2006, 333:1091-1094.
19. Kambara H, Nakagawa M, Kinoshita M, Kawai C: Long-term prognosis after
myocardial infarction: univariate and multivariate analysis of clinical
characteristics in 1,000 patients. Kyoto and Shiga Myocardial Infarction
(KYSMI) Study Group. Clin Cardiol 1993, 16:872-876.
20. Herlitz J, Bång A, Karlson BW: Five-year prognosis after acute myocardial
infarction in relation to a history of hypertension. Am J Hypertens 1996,
9:70-76.
von Känel et al. BMC Psychiatry 2011, 11:98
http://www.biomedcentral.com/1471-244X/11/98
Page 7 of 8
21. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM: Smoking
status and risk for recurrent coronary events after myocardial infarction.
Ann Intern Med 2002, 137:494-500.
22. Glassman A: Depression and cardiovascular disease. Pharmacopsychiatry
2008, 41:221-225.
23. Shemesh E, Koren-Michowitz M, Yehuda R, Milo-Cotter O, Murdock E,
Vered Z, Shneider BL, Gorman JM, Cotter G: Symptoms of posttraumatic
stress disorder in patients who have had a myocardial infarction.
Psychosomatics 2006, 47:231-239.
24. Agarwal M, Dalal AK, Agarwal DK, Agarwal RK: Positive life orientation and
recovery from myocardial infarction. Soc Sci Med 1995, 40:125-130.
25. Carney RM, Freedland KE, Eisen SA, Rich MW, Skala JA, Jaffe AS: Adherence
to a prophylactic medication regimen in patients with symptomatic
versus asymptomatic ischemic heart disease. Behav Med 1998, 24:35-39.
26. Shemesh E, Rudnick A, Kaluski E, Milovanov O, Salah A, Alon D, Dinur I,
Blatt A, Metzkor M, Golik A, Verd Z, Cotter G: A prospective study of
posttraumatic stress symptoms and nonadherence in survivors of a
myocardial infarction (MI). Gen Hosp Psychiatry 2001, 23:215-222.
27. Kraemer B, Moergeli H, Roth H, Hepp U, Schnyder U: Contribution of initial
heart rate to the prediction of posttraumatic stress symptom level in
accident victims. J Psychiatr Res 2008, 42:158-162.
28. Delahanty DL, Raimonde AJ, Spoonster E: Initial posttraumatic urinary
cortisol levels predict subsequent PTSD symptoms in motor vehicle
accident victims. Biol Psychiatry 2000, 48:940-947.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/11/98/prepub
doi:10.1186/1471-244X-11-98
Cite this article as: von Känel et al.: Distress related to myocardial
infarction and cardiovascular outcome: a retrospective observational
study. BMC Psychiatry 2011 11:98.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
von Känel et al. BMC Psychiatry 2011, 11:98
http://www.biomedcentral.com/1471-244X/11/98
Page 8 of 8
